Skip to main content
. 2019 Oct 18;317(6):H1221–H1230. doi: 10.1152/ajpheart.00409.2019

Table 2.

Solution composition

Concentration, mM
Relaxing Preactivating Activating
Ca-EGTA 10−8 10−8 10−4.3
HDTA 0.0 20.0 0.0
MgATP 5.8 5.8 5.9
Creatine phosphate 10.0 10.0 10.0
K-propionate 40.1 40.7 0.5
DTT 1.0 1.0 1.0

HDTA, 1,5-diaminohexane-N,N,N′,N′-tetraacetic acid.